Please login to the form below

Not currently logged in
Email:
Password:

LionsDen Communications Award for Excellence in Payer and Policymaker Engagement

Sponsored by

Finalist

Fresubin - seizing opportunities through adaptation

Fresenius Kabi in association with Havas Life Medicom


Summary of work

Rarely does a client marketing team and partner agency get the opportunity to evolve a campaign in real-time alongside a shifting healthcare agenda – changes in the demands put upon nutrition within healthcare created one such unique opportunity.

Historically, Fresenius Kabi’s (FK’s) enteral nutrition presence was stifled by the established dominance of Nutricia and Abbott. However, in 2008 FK saw an opportunity to move away from pure product promotion, which dominated the market, when the Department of Health (DH) launched an initiative to raise the profile of good nutritional care. 

Research showed that oral nutritional supplements (ONS) had little differentiation; consequently, FK set itself apart by positioning its range of ONS as an ethical and caring solution, better supporting healthcare providers (HCPs). 

Over the next two to three years a progressive shift in the NHS and the DH’s agenda towards appropriate and efficient care raised the priority of malnutrition further and by 2010, ONS were deemed as a burden economically. 

A realignment of existing values allowed for communication with a new joint audience of HCPs and payers, strengthening FK’s position as a partner in nutritional care. Over three years these activities increased market share in the declining ONS market from 6 per cent to 10 per cent.

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics